uniQure N.V. - Ordinary Shares (QURE): Price and Financial Metrics
uniQure N.V. - Ordinary Shares (QURE)
Today's Latest Price: $41.36 USD
Updated Aug 10 4:00pm
Add QURE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
QURE Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for QURE is 0.02 -- better than merely 9.83% of US stocks.
- QURE's price/sales ratio is 345.69; that's higher than the P/S ratio of 98.55% of US stocks.
- As for revenue growth, note that QURE's revenue has grown -36.53% over the past 12 months; that beats the revenue growth of only 6% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to uniQure NV, a group of peers worth examining would be OTIC, SNDX, CCXI, CKPT, and SYRS.
- QURE's SEC filings can be seen here. And to visit uniQure NV's official web site, go to www.uniqure.com.
QURE Stock Price Chart Technical Analysis Charts
QURE Price/Volume Stats
| Current price | $41.36 | 52-week high | $76.69 |
| Prev. close | $41.30 | 52-week low | $36.20 |
| Day low | $40.78 | Volume | 228,300 |
| Day high | $41.65 | Avg. volume | 503,797 |
| 50-day MA | $50.88 | Dividend yield | N/A |
| 200-day MA | $56.43 | Market Cap | 1.84B |
uniQure N.V. - Ordinary Shares (QURE) Company Bio
uniQure is a biopharmaceutical company, developing adeno-associated virus (AAV) based gene therapies through its technology platform for multiple therapeutic areas. The company was founded in 1998 and is based in Amsterdam, the Netherlands.
Loading social stream, please wait...